We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+9.54%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$21.6B
AUM Growth
+$3.73B
(+21%)
Cap. Flow
+$2.14B
Cap. Flow
% of AUM
9.89%
Top 10 Holdings %
Top 10 Hldgs %
20.71%
Holding
1,837
New
181
Increased
1,318
Reduced
286
Closed
50
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$34M |
| 2 |
ExxonMobil
XOM
|
+$33.1M |
| 3 |
Johnson & Johnson
JNJ
|
+$32.7M |
| 4 |
3M
MMM
|
+$32.4M |
| 5 |
McDonald's
MCD
|
+$32.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$70M |
| 2 |
W.R. Berkley
WRB
|
+$12.8M |
| 3 |
ISCA
International Speedway Corp
ISCA
|
+$11.2M |
| 4 |
CTWS
Connecticut Water Service Inc
CTWS
|
+$11.2M |
| 5 |
Gen Digital
GEN
|
+$10.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.41% |
| 2 | Financials | 12.4% |
| 3 | Industrials | 11.69% |
| 4 | Healthcare | 11.57% |
| 5 | Consumer Staples | 11.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRC
1651
DELISTED
MRC Global
MRC
| $146K | ﹤0.01% |
+10,710
| New | +$140K |
|
|
NEX
1652
DELISTED
NexTier Oilfield Solutions Inc.
NEX
| $145K | ﹤0.01% |
+21,602
| New | +$117K |
|
|
BRSP
1653
BrightSpire Capital
BRSP
$681M
| $144K | ﹤0.01% |
+10,969
| New | +$149K |
|
|
TBIO
1654
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $144K | ﹤0.01% |
17,675
+522
| +3% | +$4.82K |
|
1655
Tronox
TROX
$995M
| $141K | ﹤0.01% |
12,377
+1,978
| +19% | +$19.8K |
|
|
TRST
1656
Trustco Bank Corp NY
TRST
$1B
| $135K | ﹤0.01% |
3,111
+454
| +17% | +$19.4K |
|
|
YJ
1657
Yunji
YJ
$6.55M
| $133K | ﹤0.01% |
726
+15
| +2% | +$3.11K |
|
|
DBD
1658
DELISTED
Diebold Nixdorf Incorporated
DBD
| $133K | ﹤0.01% |
12,600
+1,810
| +17% | +$16.1K |
|
1659
CytomX Therapeutics
CTMX
$705M
| $132K | ﹤0.01% |
15,930
-1,435
| -8% | -$9.68K |
|
|
CHK
1660
DELISTED
Chesapeake Energy Corporation
CHK
| $132K | ﹤0.01% |
801
+62
| +8% | +$12.5K |
|
1661
Resideo Technologies
REZI
$5.23B
| $131K | ﹤0.01% |
+11,009
| New | +$125K |
|
1662
TG Therapeutics
TGTX
$8.58B
| $130K | ﹤0.01% |
+11,682
| New | +$88.8K |
|
|
PDLI
1663
DELISTED
PDL BioPharma, Inc.
PDLI
| $130K | ﹤0.01% |
39,965
-3,784
| -9% | -$11K |
|
|
COOP
1664
DELISTED
Mr. Cooper
COOP
| $129K | ﹤0.01% |
+10,319
| New | +$127K |
|
1665
SiriusPoint
SPNT
$2.98B
| $129K | ﹤0.01% |
12,221
+1,779
| +17% | +$17.3K |
|
|
JMIA
1666
Jumia Technologies
JMIA
$726M
| $127K | ﹤0.01% |
18,824
+379
| +2% | +$2.39K |
|
1667
Rigel Pharmaceuticals
RIGL
$680M
| $126K | ﹤0.01% |
5,905
-548
| -8% | -$11.3K |
|
1668
AC Immune
ACIU
$227M
| $124K | ﹤0.01% |
14,611
-3,679
| -20% | -$24.5K |
|
|
CISN
1669
DELISTED
Cision Ltd. Ordinary Share
CISN
| $124K | ﹤0.01% |
12,414
+1,983
| +19% | +$18.9K |
|
|
TDAY
1670
USA Today Co
TDAY
$1.23B
| $123K | ﹤0.01% |
+19,294
| New | +$141K |
|
|
OPTN
1671
DELISTED
OptiNose
OPTN
| $123K | ﹤0.01% |
886
-51
| -5% | -$6.61K |
|
1672
Acco Brands
ACCO
$369M
| $122K | ﹤0.01% |
13,067
+2,085
| +19% | +$19.7K |
|
|
CMO
1673
DELISTED
Capstead Mortgage Corp.
CMO
| $121K | ﹤0.01% |
15,278
+2,196
| +17% | +$17K |
|
1674
Corbus Pharmaceuticals
CRBP
$170M
| $120K | ﹤0.01% |
734
-75
| -9% | -$11.1K |
|
1675
Lexicon Pharmaceuticals
LXRX
$1.02B
| $119K | ﹤0.01% |
28,607
-4,889
| -15% | -$18.8K |
|
Similar funds
ProShare Advisors's Q4 2019 Portfolio in Review
As of Q4 2019, ProShare Advisors held 1,837 positions worth $21.6B, up 21% from $17.9B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
ProShare Advisors deployed $2.14B of net new capital in Q4 2019, opening 181 new positions and adding to 1,318 existing holdings. Its largest new stake was Pennant Group: 484,308 shares worth $16M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was W.R. Berkley, an estimated $12.8M trimmed.
- ProShare Advisors's largest Q4 2019 buy was Pennant Group: 484,308 shares worth $16M.
- ProShare Advisors added most to Alphabet (Google) Class A in Q4 2019, an estimated $34M increase.
- ProShare Advisors's biggest Q4 2019 reduction was W.R. Berkley, cutting an estimated $12.8M.
- ProShare Advisors fully exited Celgene Corp in Q4 2019, selling an estimated $70M.
- ProShare Advisors's ten largest holdings make up 21% of its $21.6B portfolio in Q4 2019.
- ProShare Advisors opened 181 new positions and closed 50 in Q4 2019.
- ProShare Advisors's portfolio value rose 21% quarter-over-quarter to $21.6B.
Based on ProShare Advisors's 13F filing for Q4 2019, filed 12 Feb 2020.